Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad-Ali Jenabian

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
AIDS Research and Therapy|October 20, 2023
Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIVKeely Hammond, Terry Lee, Branka Vulesevic, et al.
Retrovirology|December 15, 2015
Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approachAurélie Cleret-Buhot, Yuwei Zhang, Delphine Planas, et al.
Journal of Virology|June 14, 2019
HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral TherapyRachel L Miller, Rosalie Ponte, Bradley R Jones, et al.
Iscience|August 19, 2024
Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: Results from the Canadian HIV and Aging Cohort StudyRalph-Sydney Mboumba Bouassa, Giada Giorgini, Cristoforo Silvestri, et al.
Plos Pathogens|July 14, 2011
CD39/adenosine pathway is involved in AIDS progressionMaria Nikolova, Matthieu Carriere, Mohammad-Ali Jenabian, et al.
The Journal of Infectious Diseases|September 11, 2019
Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency VirusStéphane Isnard, Rayoun Ramendra, Franck P Dupuy, et al.
Viruses|February 28, 2023
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)Yulia Alexandrova, Alexis Yero, Ralph-Sydney Mboumba Bouassa, et al.
The Journal of Infectious Diseases|December 19, 2023
IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIVHardik Ramani, Annie Gosselin, Rémi Bunet, et al.
Cells|July 29, 2023
Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical TrialRalph-Sydney Mboumba Bouassa, Eve Comeau, Yulia Alexandrova, et al.
BMJ Open|December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort studyCecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
AIDS Research and Therapy|October 20, 2023
Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIVKeely Hammond, Terry Lee, Branka Vulesevic, et al.
Retrovirology|December 15, 2015
Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approachAurélie Cleret-Buhot, Yuwei Zhang, Delphine Planas, et al.
Journal of Virology|June 14, 2019
HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral TherapyRachel L Miller, Rosalie Ponte, Bradley R Jones, et al.
Iscience|August 19, 2024
Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: Results from the Canadian HIV and Aging Cohort StudyRalph-Sydney Mboumba Bouassa, Giada Giorgini, Cristoforo Silvestri, et al.
Plos Pathogens|July 14, 2011
CD39/adenosine pathway is involved in AIDS progressionMaria Nikolova, Matthieu Carriere, Mohammad-Ali Jenabian, et al.
The Journal of Infectious Diseases|September 11, 2019
Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency VirusStéphane Isnard, Rayoun Ramendra, Franck P Dupuy, et al.
Viruses|February 28, 2023
SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)Yulia Alexandrova, Alexis Yero, Ralph-Sydney Mboumba Bouassa, et al.
The Journal of Infectious Diseases|December 19, 2023
IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIVHardik Ramani, Annie Gosselin, Rémi Bunet, et al.
Cells|July 29, 2023
Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical TrialRalph-Sydney Mboumba Bouassa, Eve Comeau, Yulia Alexandrova, et al.
BMJ Open|December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort studyCecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Pageof 11